On November 22, 2022 Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, reported that the company will participate in the Piper Sandler 34th Annual Healthcare Conference, which takes place November 29-December 1, 2022 in New York City, New York (Press release, Akebia, NOV 22, 2022, View Source/news-releases/news-release-details/akebia-therapeutics-participate-piper-sandler-34th-annual" target="_blank" title="View Source/news-releases/news-release-details/akebia-therapeutics-participate-piper-sandler-34th-annual" rel="nofollow">View Source [SID1234624401]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

John P. Butler, Chief Executive Officer of Akebia Therapeutics, will participate in a fireside chat on Tuesday, November 29 at 2:30 p.m. ET.

A webcast of the fireside chat will be available through the Investors section of Akebia’s website at View Source for approximately 90 days following the conference.